Carboxylesterase Notum Is a Druggable Target to Modulate Wnt Signaling
By E. D. Bayle, Fredrik Svensson, Benjamin N. Atkinson, D. Steadman, N. Willis, H. Woodward, P. Whiting, J. Vincent, Paul V. Fish. 2021
46 citations recorded by the source corpus.
Regulation of the Wnt signaling pathway is critically important for a number of cellular processes in both development and adult mammalian biology. This Perspective will provide a summary of current and emerging therapeutic opportunities in modulating Wnt signaling, especially through inhibition of Notum carboxylesterase activity. Notum was recently shown to act as a negative regulator of Wnt signaling through the removal of an essential palmitoleate group. Inhibition of Notum activity may represent a new approach to treat disease where aberrant Notum activity has been identified as the underlying cause. Reliable screening technologies are available to identify inhibitors of Notum, and structural studies are accelerating the discovery of new inhibitors. A selection of these hits have been optimized to give fit-for-purpose small molecule inhibitors of Notum. Three noteworthy examples are LP-922056 (26), ABC99 (27), and ARUK3001185 (28), which are complementary chemical tools for exploring the role of Notum in Wnt signaling.
Subfields: Molecular Biology, Pharmacology
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
Citations in the corpus
- Designed switch from covalent to non-covalent inhibitors of carboxylesterase Notum activity (2023, background): “Notum has been proposed as a druggable target with reliable screening technologies, multiple structural studies and fit-for-purpose small molecule inhibitors available [8,9].”